Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Safety and Efficacy Assessments of NeoKidney® in ESRD Patients Treated With Short Daily Hemodialysis
Phase: N/A
Priority: Normal
Start: 03/11/24
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 02/22/24
End: 04/24/24
Due: 04/24/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Efficacy Assessments of NeoKidney® in ESRD Patients Treated With Short Daily Hemodialysis | NCT06024135 | Nextkidney S.A. | user2@example.com | None | 2024-03-11 | 2024-06-30 | 2025-06-30 | - | - | 2025-07-14 |
| Early Feasibility Study to Evaluate the Safety and Efficacy of PAK HD in ESRD Patients | NCT06433193 | Nextkidney S.A. | user2@example.com | None | 2024-02-22 | 2024-04-24 | 2025-04-24 | - | - | 2025-07-14 |